Literature DB >> 11937713

Vinexin, CAP/ponsin, ArgBP2: a novel adaptor protein family regulating cytoskeletal organization and signal transduction.

Noriyuki Kioka1, Kazumitsu Ueda, Teruo Amachi.   

Abstract

Adaptor proteins, composed of two or more protein-protein interacting modules without enzymatic activity, regulate various cellular functions. Vinexin, CAP/ponsin, and ArgBP2 constitute a novel adaptor protein family. They have a novel conserved region homologous to the active peptide sorbin, as well as three SH3 (src homology 3) domains. A number of proteins binding to this adaptor family have been identified. There is accumulating evidence that this protein family regulates cell adhesion, cytoskeletal organization, and growth factor signaling. This review will summarize the structure and the function of proteins in this family.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11937713     DOI: 10.1247/csf.27.1

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  63 in total

1.  Cell biological characterization of a multidomain adaptor protein, ArgBP2, in epithelial NMuMG cells, and identification of a novel short isoform.

Authors:  Kana Murase; Hidenori Ito; Hiroyuki Kanoh; Kaori Sudo; Ikuko Iwamoto; Rika Morishita; Philippe Soubeyran; Mariko Seishima; Koh-Ichi Nagata
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

2.  CAP interacts with cytoskeletal proteins and regulates adhesion-mediated ERK activation and motility.

Authors:  Mei Zhang; Jun Liu; Alan Cheng; Stephanie M Deyoung; Xiaowei Chen; Lisa H Dold; Alan R Saltiel
Journal:  EMBO J       Date:  2006-11-02       Impact factor: 11.598

3.  Interaction of a multi-domain adaptor protein, vinexin, with a Rho-effector, Rhotekin.

Authors:  Koh-Ichi Nagata; Hidenori Ito; Ikuko Iwamoto; Rika Morishita; Tomiko Asano
Journal:  Med Mol Morphol       Date:  2009-03-18       Impact factor: 2.309

4.  PP2A regulatory subunit Bα controls endothelial contractility and vessel lumen integrity via regulation of HDAC7.

Authors:  Maud Martin; Ilse Geudens; Jonathan Bruyr; Michael Potente; Anouk Bleuart; Marielle Lebrun; Nicolas Simonis; Christophe Deroanne; Jean-Claude Twizere; Philippe Soubeyran; Paul Peixoto; Denis Mottet; Veerle Janssens; Wolf-Karsten Hofmann; Filip Claes; Peter Carmeliet; Richard Kettmann; Holger Gerhardt; Franck Dequiedt
Journal:  EMBO J       Date:  2013-08-16       Impact factor: 11.598

5.  Modulation of dorsal root ganglion development by ErbB signaling and the scaffold protein Sorbs3.

Authors:  Sarah J Malmquist; Alexandra Abramsson; Hillary F McGraw; Tor H Linbo; David W Raible
Journal:  Development       Date:  2013-09-04       Impact factor: 6.868

6.  Arg kinase-binding protein 2 (ArgBP2) interaction with α-actinin and actin stress fibers inhibits cell migration.

Authors:  Praju Vikas Anekal; Jeffery Yong; Ed Manser
Journal:  J Biol Chem       Date:  2014-11-26       Impact factor: 5.157

7.  A temporal transcriptome and methylome in human embryonic stem cell-derived cardiomyocytes identifies novel regulators of early cardiac development.

Authors:  Kai Fu; Haruko Nakano; Marco Morselli; Tiffany Chen; Herman Pappoe; Atsuschi Nakano; Matteo Pellegrini
Journal:  Epigenetics       Date:  2018-10-19       Impact factor: 4.528

8.  4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.

Authors:  Qin Yang; Min Zhu; Zi Wang; Hui Li; Weihua Zhou; Xiaojuan Xiao; Bin Zhang; Weixin Hu; Jing Liu
Journal:  Tumour Biol       Date:  2016-07-22

9.  A crucial role in cell spreading for the interaction of Abl PxxP motifs with Crk and Nck adaptors.

Authors:  Susumu Antoku; Kalle Saksela; Gonzalo M Rivera; Bruce J Mayer
Journal:  J Cell Sci       Date:  2008-09-15       Impact factor: 5.285

10.  Cbl-associated protein is tyrosine phosphorylated by c-Abl and c-Src kinases.

Authors:  Inga Fernow; Ana Tomasovic; Ann Siehoff-Icking; Ritva Tikkanen
Journal:  BMC Cell Biol       Date:  2009-11-05       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.